Typical pathogens (Staphylococcus aureus (MSSA) · group A Streptococcus · group B Streptococcus · enteric Gram-negative bacilli (E. coli, Klebsiella) · polymicrobial flora in delayed presentation)
Clinical context (Umbilical stump infection in neonates (usually ≤28 days) — erythema, induration, tenderness, or purulent discharge without systemic toxicity; progression to sepsis or NSTI can be rapid)
First-line therapy
Ampicillin • i.v. • 50–50 mg/kg/dose • 3×/day
Max 2000 mg/dose · Max 8000 mg/day · Duration: 7–10 days · Neonatal non-meningitis dosing — interval varies by GA/PNA and renal function (see high-dose indications)
• Hospital admission is generally recommended for neonates with omphalitis (risk of rapid progression) — use IV antibiotics and close observation (WHO newborn infection guidance, AAP Red Book, CPS neonatal SBI principles).
• Ampicillin neonatal intervals (non-meningitis): q8h–q12h by GA/PNA; PNA >28 days may use q6h in older infants — follow local NICU dosing table and adjust for renal function (Red Book, Nelson's). Calculator uses 50 mg/kg q8h as term-neonate fallback.
• Gentamicin in neonates: use extended-interval dosing by GA/PNA (Red Book/Nelson): GA <30 weeks PNA ≤14 days 5 mg/kg q48h; GA 30–34 weeks PNA ≤10 days 5 mg/kg q36h; GA ≥35 weeks PNA ≤7 days 4 mg/kg q24h; GA ≥35 weeks PNA 8–60 days 5 mg/kg q24h. Calculator fallback 5 mg/kg once daily for term neonate — verify interval with NICU protocol and TDM.
• Reassess at 24–48 h: if erythema spreads, pain disproportionate, bullae/skin necrosis appear, or systemic signs develop — manage as severe/NSTI; broaden therapy and involve surgery urgently.
• De-escalate at 48–72 h based on blood/wound cultures and clinical response — narrow to MSSA agent (oxacillin/nafcillin) if appropriate; avoid prolonged broad-spectrum exposure without indication (AAP/CPS stewardship principles).
Enter weight on Kids to calculate doses
Gentamicin • i.v./i.m. • 5–5 mg/kg/dose • 1×/day
Max 80 mg/dose · Duration: 7–10 days · Extended-interval aminoglycoside — dose and interval vary by GA/PNA (see high-dose indications); monitor levels if therapy >48–72 h
Enter weight on Kids to calculate doses
Oxacillin • i.v. • 25–50 mg/kg/dose • 3×/day
Max 2000 mg/dose · Max 12000 mg/day · Duration: 7–10 days · Antistaphylococcal penicillin for MSSA — nafcillin is an equivalent alternative per local formulary; neonatal interval varies by GA/PNA
• Switch to oxacillin/nafcillin when cultures confirm MSSA or when purulent omphalitis strongly suggests S. aureus — narrower than ampicillin-based regimen (AAP Red Book).
• Continue ampicillin + gentamicin when broader neonatal sepsis coverage is prioritized (GBS, Listeria, enteric Gram-negatives) while awaiting cultures (WHO newborn infection guidance, neonatal SBI principles).
• Add vancomycin when MRSA risk factors present (prior MRSA colonization, healthcare exposure, high local MRSA prevalence, severe toxicity, or failure on beta-lactam at 48 h) — see severe/MRSA variant dosing.
• Add anaerobic coverage (metronidazole or clindamycin) if foul-smelling discharge, crepitus, skin necrosis, or rapid progression suggests polymicrobial NSTI (IDSA NSTI principles; omphalitis reviews).
• If clinical deterioration or shock: treat as neonatal sepsis, obtain cultures, and manage in NICU with neonatology/ID/surgery involvement.
Enter weight on Kids to calculate doses
Gentamicin • i.v./i.m. • 5–5 mg/kg/dose • 1×/day
Max 80 mg/dose · Duration: 7–10 days · Extended-interval dosing by GA/PNA — monitor serum levels if prolonged therapy
Enter weight on Kids to calculate doses
Clinical notes
• Local vs systemic signs: localized erythema/induration and purulent discharge may be the only early findings; systemic infection includes fever or hypothermia, lethargy, poor feeding, apnea, tachycardia, hypotension, or abnormal perfusion — treat systemic signs as sepsis until proven otherwise.
• Cultures: obtain blood cultures in all suspected neonatal omphalitis before antibiotics when feasible; obtain wound/umbilical discharge culture if purulence present or if not improving — do not delay therapy in unstable infants.
• Hospital admission: neonates with suspected omphalitis generally require admission for IV antibiotics and close monitoring; outpatient management is not recommended if age ≤28 days or if follow-up cannot be ensured.
• When to suspect NSTI/necrotizing fasciitis: rapidly spreading erythema, severe or disproportionate pain, skin discoloration, bullae, crepitus, necrosis, or failure to improve within 24–48 h — urgent surgical evaluation and broad-spectrum therapy required.
• Duration: typically 7–10 days for uncomplicated localized infection; extend to 10–14 days for slow response, bacteremia, deeper infection, or after surgical intervention — tailor to clinical course and cultures.
• AAP Red Book — Omphalitis, neonatal sepsis, and staphylococcal infections (2024)
